The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange
Abstract
Antibodies play a central role in immunity by forming an interface with the innate immune system and, typically, mediate proinflammatory activity. We describe a novel posttranslational modification that leads to anti-inflammatory activity of antibodies of immunoglobulin G, isotype 4 (IgG4). IgG4 antibodies are dynamic molecules that exchange Fab arms by swapping a heavy chain and attached light chain (half-molecule) with a heavy-light chain pair from another molecule, which results in bispecific antibodies. Mutagenesis studies revealed that the third constant domain is critical for this activity. The impact of IgG4 Fab arm exchange was confirmed in vivo in a rhesus monkey model with experimental autoimmune myasthenia gravis. IgG4 Fab arm exchange is suggested to be an important biological mechanism that provides the basis for the anti-inflammatory activity attributed to IgG4 antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
THE COVALENT STRUCTURE OF AN ENTIRE γG IMMUNOGLOBULIN MOLECULE
Edelman, G. M., Cunningham, B. A., Gall, W. E., Gottlieb, P. D., Rutishauser, U., & Waxdal, M. J. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.63.1.78 · Cited by 901
Junghans, R. P., & Anderson, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5512 · Cited by 684
Teeling, J. L. (2004) · Blood · doi:10.1182/blood-2004-01-0039 · Cited by 630
Aalberse, R. C., & Schuurman, J. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01341.x · Cited by 449
Self-citationContrasting IgG Structures Reveal Extreme Asymmetry and Flexibility
Saphire, E. O., Stanfield, R. L., Max Crispin, M. D., Parren, P. W. H. I., Rudd, P. M., Dwek, R. A., Burton, D. R., & Wilson, I. A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00244-9 · Cited by 243
Self-citationInhibition of complement activation by IgG4 antibodies.
van der Zee, J. S., van Swieten, P., & Aalberse, R. C. (1986) · PubMed · Cited by 223
Self-citationvan der Zee, J. S., van Swieten, P., & Aalberse, R. C. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.11.3566 · Cited by 184
Self-citationThe inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds
Schuurman, J., Perdok, G. J., Gorter, A. D., & Aalberse, R. C. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00050-5 · Cited by 174
Self-citation
Cited by
IgG Subclasses and Allotypes: From Structure to Effector Functions
Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667
Stone, J. H., Zen, Y., & Deshpande, V. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1104650 · Cited by 2,616
Structure and function of immunoglobulins
Schroeder, H. W., & Cavacini, L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.046 · Cited by 1,905
Bispecific antibodies: a mechanistic review of the pipeline
Labrijn, A. F., Janmaat, M. L., Reichert, J. M., & Parren, P. W. H. I. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0028-1 · Cited by 1,303
Self-citationKamisawa, T., Zen, Y., Pillai, S., & Stone, J. H. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60720-0 · Cited by 1,212
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S., Eagar, T. N., & Forsthuber, T. G. (2015) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,160
The safety and side effects of monoclonal antibodies
Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A., & George, A. J. T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3003 · Cited by 1,144
The making of bispecific antibodies
Brinkmann, U., & Kontermann, R. E. (2017) · mAbs · doi:10.1080/19420862.2016.1268307 · Cited by 923
Immunological mechanisms of allergen-specific immunotherapy
Larché, M., Akdis, C. A., & Valenta, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1934 · Cited by 849
Therapeutic antibodies for autoimmunity and inflammation
Chan, A. C., & Carter, P. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2761 · Cited by 837
Immunoglobulin G4: an odd antibody
Aalberse, R. C., Stapel, S. O., Schuurman, J., & Rispens, T. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03207.x · Cited by 818
Self-citationMechanisms of allergen-specific immunotherapy
Akdis, C. A., & Akdis, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.030 · Cited by 803
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details
Umehara, H., Okazaki, K., Masaki, Y., Kawano, M., Yamamoto, M., Saeki, T., Matsui, S., Sumida, T., Mimori, T., Tanaka, Y., et al. (2012) · Modern Rheumatology · doi:10.3109/s10165-011-0508-6 · Cited by 680
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
van de Veen, W., Stanic, B., Yaman, G., Wawrzyniak, M., Söllner, S., Akdis, D. G., Rückert, B., Akdis, C. A., & Akdis, M. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.014 · Cited by 652
Antibody Structure and Function: The Basis for Engineering Therapeutics
Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L. (2019) · Antibodies · doi:10.3390/antib8040055 · Cited by 638
B cells, plasma cells and antibody repertoires in the tumour microenvironment
Sharonov, G. V., Serebrovskaya, E. O., Yuzhakova, D. V., Britanova, O. V., & Chudakov, D. M. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0257-x · Cited by 627
Alternative molecular formats and therapeutic applications for bispecific antibodies
Spiess, C., Zhai, Q., & Carter, P. J. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.01.003 · Cited by 607
Regulation of the host immune system by helminth parasites
Maizels, R. M., & McSorley, H. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.007 · Cited by 529
Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
Weiskopf, K., Ring, A. M., Ho, C. C. M., Volkmer, J.-P., Levin, A. M., Volkmer, A. K., Özkan, E., Fernhoff, N. B., van de Rijn, M., Weissman, I. L., et al. (2013) · Science · doi:10.1126/science.1238856 · Cited by 495
Antibody–drug conjugates as novel anti-cancer chemotherapeutics
Peters, C., & Brown, S. (2015) · Bioscience Reports · doi:10.1042/bsr20150089 · Cited by 492
Liu, H., & May, K. (2012) · mAbs · doi:10.4161/mabs.4.1.18347 · Cited by 484
Schaefer, W., Regula, J. T., Bähner, M., Schanzer, J., Croasdale, R., Dürr, H., Gassner, C., Georges, G., Kettenberger, H., Imhof-Jung, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019002108 · Cited by 482
Physicochemical Stability of Monoclonal Antibodies: A Review
Le Basle, Y., Chennell, P., Tokhadze, N., Astier, A., & Sautou, V. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.08.009 · Cited by 429
Antibody-Drug Conjugates for Cancer Therapy
Carter, P. J., & Senter, P. D. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e318172d704 · Cited by 429
Garcês, S., Demengeot, J., & Benito-Garcia, E. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202220 · Cited by 411
Recent Advances in Autoimmune Pancreatitis
Hart, P. A., Zen, Y., & Chari, S. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.010 · Cited by 400
Shamji, M. H., Kappen, J. H., Akdis, M., Jensen‐Jarolim, E., Knol, E. F., Kleine‐Tebbe, J., Bohle, B., Chaker, A. M., Till, S. J., Valenta, R., et al. (2017) · Allergy · doi:10.1111/all.13138 · Cited by 382
Mahajan, V. S., Mattoo, H., Deshpande, V., Pillai, S. S., & Stone, J. H. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104708 · Cited by 366
Type 2 immunity in allergic diseases
Ogulur, I., Mitamura, Y., Yazici, D., Pat, Y., Ardicli, S., Li, M., D’Avino, P., Beha, C., Babayev, H., Zhao, B., et al. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01261-2 · Cited by 362
Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
Akdis, C. A., & Akdis, M. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0063-2 · Cited by 361
Advances in the diagnosis and management of IgG4 related disease
Lanzillotta, M., Mancuso, G., & Della-Torre, E. (2020) · BMJ · doi:10.1136/bmj.m1067 · Cited by 360
James, L. K., Shamji, M. H., Walker, S. M., Wilson, D. R., Wachholz, P. A., Francis, J. N., Jacobson, M. R., Kimber, I., Till, S. J., & Durham, S. R. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1080 · Cited by 342
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
Labrijn, A. F., Meesters, J. I., de Goeij, B. E. C. G., van den Bremer, E. T. J., Neijssen, J., van Kampen, M. D., Strumane, K., Verploegen, S., Kundu, A., Gramer, M. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220145110 · Cited by 339
Self-citationMechanisms and treatment of allergic disease in the big picture of regulatory T cells
Akdis, C. A., & Akdis, M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.030 · Cited by 337
Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
Jefferis, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.04.007 · Cited by 330
Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells
Palomares, O., Akdis, M., Martín‐Fontecha, M., & Akdis, C. A. (2017) · Immunological Reviews · doi:10.1111/imr.12555 · Cited by 330
What is IgG4? A review of the biology of a unique immunoglobulin subtype
Nirula, A., Glaser, S. M., Kalled, S. L., & Taylora, F. R. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283412fd4 · Cited by 309
Bispecific Antibodies: From Research to Clinical Application
Ma, J., Mo, Y., Tang, M., Shen, J., Qi, Y., Zhao, W., Huang, Y., Xu, Y., & Qian, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626616 · Cited by 305
Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll‐like receptors
Meiler, F., Klunker, S., Zimmermann, M., Akdis, C. A., & Akdis, M. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01774.x · Cited by 302
Considerations for the Design of Antibody-Based Therapeutics
Goulet, D. R., & Atkins, W. M. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.05.031 · Cited by 302
Avidity in antibody effector functions and biotherapeutic drug design
Oostindie, S. C., Lazar, G. A., Schuurman, J., & Parren, P. W. H. I. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00501-8 · Cited by 298
Self-citationTherapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo
Labrijn, A. F., Buijsse, A. O., van den Bremer, E. T. J., Verwilligen, A. Y. W., Bleeker, W. K., Thorpe, S. J., Killestein, J., Polman, C. H., Aalberse, R. C., Schuurman, J., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1553 · Cited by 298
Self-citationShamji, M. H., Ljørring, C., Francis, J. N., A Calderon, M., Larché, M., Kimber, I., Frew, A. J., Ipsen, H., Lund, K., Würtzen, P. A., et al. (2012) · Allergy · doi:10.1111/j.1398-9995.2011.02745.x · Cited by 297
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4
Huijbers, M. G., Zhang, W., Klooster, R., Niks, E. H., Friese, M. B., Straasheijm, K. R., Thijssen, P. E., Vrolijk, H., Plomp, J. J., Vogels, P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313944110 · Cited by 297
Self-citationTherapies for allergic inflammation: refining strategies to induce tolerance
Akdis, C. A. (2012) · Nature Medicine · doi:10.1038/nm.2754 · Cited by 296
Affinity of human IgG subclasses to mouse Fc gamma receptors
Dekkers, G., Bentlage, A. E. H., Stegmann, T. C., Howie, H. L., Lissenberg-Thunnissen, S., Zimring, J., Rispens, T., & Vidarsson, G. (2017) · mAbs · doi:10.1080/19420862.2017.1323159 · Cited by 293
Bispecific antibodies: design, therapy, perspectives
Sedykh, S., Prinz, V., Buneva, V., & Nevinsky, G. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s151282 · Cited by 292
Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease
Okazaki, K., Uchida, K., Koyabu, M., Miyoshi, H., & Takaoka, M. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0386-x · Cited by 292
Human IgG2 Antibodies Display Disulfide-mediated Structural Isoforms
Wypych, J., Li, M., Guo, A., Zhang, Z., Martinez, T., Allen, M. J., Fodor, S., Kelner, D. N., Flynn, G. C., Liu, Y. D., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709987200 · Cited by 286
The growth and potential of human antiviral monoclonal antibody therapeutics
Marasco, W. A., & Sui, J. (2007) · Nature Biotechnology · doi:10.1038/nbt1363 · Cited by 284
The Unique Properties of IgG4 and Its Roles in Health and Disease
Rispens, T., & Huijbers, M. G. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00871-z · Cited by 282
Immunological mechanisms of allergen-specific immunotherapy
Jutel, M., & Akdis, C. A. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02589.x · Cited by 279
Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab
Scapin, G., Yang, X., Prosise, W. W., McCoy, M., Reichert, P., Johnston, J. M., Kashi, R. S., & Strickland, C. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3129 · Cited by 259
Role of regulatory B cells in immune tolerance to allergens and beyond
van de Veen, W., Stanic, B., Wirz, O. F., Jansen, K., Globinska, A., & Akdis, M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.006 · Cited by 258
Developability Assessment During the Selection of Novel Therapeutic Antibodies
Jarasch, A., Koll, H., Regula, J. T., Bader, M., Papadimitriou, A., & Kettenberger, H. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24430 · Cited by 242
Crudele, J. M., Finn, J. D., Siner, J. I., Martin, N. B., Niemeyer, G. P., Zhou, S., Mingozzi, F., Lothrop, C. D., & Arruda, V. R. (2015) · Blood · doi:10.1182/blood-2014-07-588194 · Cited by 153
Suárez-Fueyo, A., Ramos, T., Galán, A., Jimeno, L., Wurtzen, P. A., Marin, A., de Frutos, C., Blanco, C., Carrera, A. C., Barber, D., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.043 · Cited by 147
Exposure to occupational antigens might predispose to IgG4-related disease
de Buy Wenniger, L. J. M., Culver, E. L., & Beuers, U. (2014) · Hepatology · doi:10.1002/hep.26999 · Cited by 124
“Serum IgG4 concentrations are generally elevated in IgG4-RD but the biological implications thereof have not been explained.(3) IgG4, traditionally regarded as a regulatory antibody, has been consistently reported to be upregulated in chronic immune stimulation, as illustrated by an elevation of bee-venom-specific IgG…”
BackgroundAdvances in allergen immunotherapy: Aiming for complete tolerance to allergens
Akdis, C. A., & Akdis, M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa7390 · Cited by 118
Regulatory T‐cells in helminth infection: induction, function and therapeutic potential
White, M. P. J., McManus, C. M., & Maizels, R. M. (2020) · Immunology · doi:10.1111/imm.13190 · Cited by 114
Increased IgG4 levels in children with autism disorder
Enstrom, A., Krakowiak, P., Onore, C., Pessah, I. N., Hertz-Picciotto, I., Hansen, R. L., Van de Water, J. A., & Ashwood, P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.12.005 · Cited by 101
“These features drastically alter the biological function of the IgG4 antibody, shifting its function to that of a blocking or inhibiting antibody rather than one of protection through the more conventional routes, such as complement fixation (van der Neut Kolfschoten et al., 2007).”
Human Fc Receptor–Like 5 Binds Intact IgG via Mechanisms Distinct from Those of Fc Receptors
Franco, A., Damdinsuren, B., Ise, T., Dement-Brown, J., Li, H., Nagata, S., & Tolnay, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202860 · Cited by 85
The clinical significance of allergen-specific IgG4 in allergic diseases
Qin, L., Tang, L.-F., Cheng, L., & Wang, H.-Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1032909 · Cited by 71
Gorovits, B., Azadeh, M., Buchlis, G., Harrison, T., Havert, M., Jawa, V., Long, B., McNally, J., Milton, M., Nelson, R., et al. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00628-3 · Cited by 53
CD5L is a canonical component of circulatory IgM
(2023) · doi:10.1073/pnas.2311265120 · Cited by 47
Increased in vivo effector function of human IgG4 isotype antibodies through afucosylation
Gong, Q., Hazen, M., Marshall, B., Crowell, S. R., Ou, Q., Wong, A. W., Phung, W., Vernes, J.-M., Meng, Y. G., Tejada, M., et al. (2016) · mAbs · doi:10.1080/19420862.2016.1189049 · Cited by 26
“alternative with a preferred version having the hinge mutation S228P (Eu numbering) to stabilize the antibody against Fab arm exchange.(12) Although in general IgG4 isotype antibodies have reduced capacity to support in vitro ADCC, in vivo target cell depletion activity in humans has been noted with an IgG4 version of…”
BackgroundMechanisms and Biomarkers of Successful Allergen-Specific Immunotherapy
López, J.-F., Bel Imam, M., Satitsuksanoa, P., Lems, S., Yang, M., Hwang, Y.-K., Losol, P., Choi, J.-P., Kim, S.-H., Chang, Y.-S., et al. (2022) · Asia Pacific Allergy · doi:10.5415/apallergy.2022.12.e45 · Cited by 25
Arsiwala, A., Bhatt, R., van Niekerk, L., Quintero-Cadena, P., Ao, X., Rosenbaum, A., Bhatt, A., Smith, A., Yang, Y., Anderson, K., et al. (2025) · mAbs · doi:10.1080/19420862.2025.2593055 · Cited by 16
Metadata
- Authors
- van der Neut Kolfschoten, M., Schuurman, J., Losen, M., Bleeker, W. K., Martínez-Martínez, P., Vermeulen, E., den Bleker, T. H., Wiegman, L., Vink, T., Aarden, L. A., De Baets, M. H., van de Winkel, J. G. J., Aalberse, R. C., & Parren, P. W. H. I.
- Venue
- Science
- Published
- 2007-09-14
- Volume
- 317
- Issue
- 5844
- Pages
- 1554-1557
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1986864699
- Cited by
- 975
- References
- 16
- FWCI
- 25.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.